167 related articles for article (PubMed ID: 35972892)
1. METTL3-induced DLGAP1-AS2 promotes non-small cell lung cancer tumorigenesis through m
Zhang Q; Zhang Y; Chen H; Sun LN; Zhang B; Yue DS; Wang CL; Zhang ZF
Cell Cycle; 2022 Dec; 21(24):2602-2614. PubMed ID: 35972892
[TBL] [Abstract][Full Text] [Related]
2. LncRNA DLGAP1-AS2 regulates miR-503/cyclin D1 to promote cell proliferation in non-small cell lung cancer.
Wang L; Tang L; Ge T; Zhu F; Liu D; Guo H; Qian P; Xu N
BMC Pulm Med; 2021 Aug; 21(1):277. PubMed ID: 34454450
[TBL] [Abstract][Full Text] [Related]
3. DLGAP1-AS2 promotes human colorectal cancer progression through trans-activation of Myc.
Ren C; Han H; Pan J; Chang Q; Wang W; Guo X; Bian J
Mamm Genome; 2022 Dec; 33(4):672-683. PubMed ID: 36222892
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA DLGAP1-AS2 promotes tumorigenesis and metastasis by regulating the Trim21/ELOA/LHPP axis in colorectal cancer.
Wang X; Cheng H; Zhao J; Li J; Chen Y; Cui K; Tian L; Zhang J; Li C; Sun S; Feng Y; Yao S; Bian Z; Huang S; Fei B; Huang Z
Mol Cancer; 2022 Nov; 21(1):210. PubMed ID: 36376892
[TBL] [Abstract][Full Text] [Related]
5. The knockdown of lncRNA DLGAP1-AS2 suppresses osteosarcoma progression by inhibiting aerobic glycolysis via the miR-451a/HK2 axis.
Zheng C; Li R; Zheng S; Fang H; Xu M; Zhong L
Cancer Sci; 2023 Dec; 114(12):4747-4762. PubMed ID: 37817462
[TBL] [Abstract][Full Text] [Related]
6. The m6A modification-mediated positive feedback between glycolytic lncRNA SLC2A1-DT and c-Myc promotes tumorigenesis of hepatocellular carcinoma.
Zeng Z; Wang J; Xu F; Hu P; Hu Y; Zhuo W; Chen D; Han S; Wang F; Zhao Y; Huang Y; Zhao G
Int J Biol Sci; 2024; 20(5):1744-1762. PubMed ID: 38481809
[TBL] [Abstract][Full Text] [Related]
7. Long non-coding RNA DLGAP1-AS1 modulates the development of non-small-cell lung cancer via the microRNA-193a-5p/DTL axis.
Pan X; Chen S; Ye L; Xu S; Wang L; Sun Y
Lab Invest; 2022 Nov; 102(11):1182-1191. PubMed ID: 36183046
[TBL] [Abstract][Full Text] [Related]
8. m
Xue L; Li J; Lin Y; Liu D; Yang Q; Jian J; Peng J
J Cell Physiol; 2021 Apr; 236(4):2649-2658. PubMed ID: 32892348
[TBL] [Abstract][Full Text] [Related]
9. Long Non-coding RNA DLGAP1-AS1 and DLGAP1-AS2: Two Novel Oncogenes in Multiple Cancers.
Zhao F; Tan F; Tang L; Du Z; Chen X; Yang Y; Zhou G; Yuan C
Curr Med Chem; 2023; 30(25):2822-2834. PubMed ID: 36121088
[TBL] [Abstract][Full Text] [Related]
10. LncRNA DLGAP1-AS2 overexpression associates with gastric tumorigenesis: a promising diagnostic and therapeutic target.
Soltani R; Amini M; Mazaheri Moghaddam M; Jebelli A; Ahmadiyan S; Bidar N; Baradaran B; MotieGhader H; Asadi M; Mokhtarzadeh A
Mol Biol Rep; 2022 Jul; 49(7):6817-6826. PubMed ID: 34981339
[TBL] [Abstract][Full Text] [Related]
11. LINC01123, a c-Myc-activated long non-coding RNA, promotes proliferation and aerobic glycolysis of non-small cell lung cancer through miR-199a-5p/c-Myc axis.
Hua Q; Jin M; Mi B; Xu F; Li T; Zhao L; Liu J; Huang G
J Hematol Oncol; 2019 Sep; 12(1):91. PubMed ID: 31488218
[TBL] [Abstract][Full Text] [Related]
12. METTL3-stabilized lncRNA SNHG7 accelerates glycolysis in prostate cancer via SRSF1/c-Myc axis.
Liu J; Yuan JF; Wang YZ
Exp Cell Res; 2022 Jul; 416(1):113149. PubMed ID: 35405116
[TBL] [Abstract][Full Text] [Related]
13. DLGAP1-AS2 promotes estrogen receptor signalling and confers tamoxifen resistance in breast cancer.
Liang X; Zhao Y; Fang Z; Shao N; Zhai D; Zhang M; Yu L; Shi Y
Mol Biol Rep; 2022 May; 49(5):3939-3947. PubMed ID: 35449318
[TBL] [Abstract][Full Text] [Related]
14. Long non-coding RNA LPP-AS2 promotes glioma tumorigenesis via miR-7-5p/EGFR/PI3K/AKT/c-MYC feedback loop.
Zhang X; Niu W; Mu M; Hu S; Niu C
J Exp Clin Cancer Res; 2020 Sep; 39(1):196. PubMed ID: 32962742
[TBL] [Abstract][Full Text] [Related]
15. LncRNA DLGAP1-AS2 modulates glioma development by up-regulating YAP1 expression.
Miao W; Li N; Gu B; Yi G; Su Z; Cheng H
J Biochem; 2020 Apr; 167(4):411-418. PubMed ID: 31899508
[TBL] [Abstract][Full Text] [Related]
16. lncRNA DLGAP1-AS2 Knockdown Inhibits Hepatocellular Carcinoma Cell Migration and Invasion by Regulating miR-154-5p Methylation.
Chen K; Zhang Z; Yu A; Li J; Liu J; Zhang X
Biomed Res Int; 2020; 2020():6575724. PubMed ID: 33195697
[TBL] [Abstract][Full Text] [Related]
17. The long noncoding RNA DLGAP1-AS2 facilitates cholangiocarcinoma progression via miR-505 and GALNT10.
Liu Z; Pan L; Yan X; Duan X
FEBS Open Bio; 2021 Feb; 11(2):413-422. PubMed ID: 33301605
[TBL] [Abstract][Full Text] [Related]
18. N
Huang T; Cao L; Feng N; Xu B; Dong Y; Wang M
Bioengineered; 2021 Dec; 12(2):10935-10944. PubMed ID: 34866525
[TBL] [Abstract][Full Text] [Related]
19. METTL3 promotes non-small cell lung cancer (NSCLC) cell proliferation and colony formation in a m6A-YTHDF1 dependent way.
Dou X; Wang Z; Lu W; Miao L; Zhao Y
BMC Pulm Med; 2022 Aug; 22(1):324. PubMed ID: 36008805
[TBL] [Abstract][Full Text] [Related]
20. m
Jin D; Guo J; Wu Y; Du J; Yang L; Wang X; Di W; Hu B; An J; Kong L; Pan L; Su G
J Hematol Oncol; 2019 Dec; 12(1):135. PubMed ID: 31818312
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
